Cargando…

Improving the quality of life in patients with chronic obstructive pulmonary disease: focus on indacaterol

Chronic obstructive pulmonary disease (COPD) is a common disease in the general population and it places a considerable burden on patients, with the disease negatively affecting quality of life. In practice, patients with COPD generally seek medical attention because of symptoms, particularly breath...

Descripción completa

Detalles Bibliográficos
Autor principal:	Feldman, Gregory J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575129/ https://www.ncbi.nlm.nih.gov/pubmed/23431038 http://dx.doi.org/10.2147/COPD.S31209

Ejemplares similares

Comparative efficacy of indacaterol in chronic obstructive pulmonary disease
por: Ribeiro, Marcos, et al.
Publicado: (2012)

Indacaterol improves daily physical activity in patients with chronic obstructive pulmonary disease
por: Hataji, Osamu, et al.
Publicado: (2013)

Safety and Effectiveness of Indacaterol in Chronic Obstructive Pulmonary Disease Patients in South Korea
por: Yum, Ho-Kee, et al.
Publicado: (2017)

Indacaterol for Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis
por: Chung, Vincent C. H., et al.
Publicado: (2013)

Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary disease
por: Nishijima, Yu, et al.
Publicado: (2015)

Direct Switch from Tiotropium to Indacaterol/Glycopyrronium in Chronic Obstructive Pulmonary Disease Patients in Korea
por: Lee, Sang Haak, et al.
Publicado: (2021)

Efficacy of indacaterol on quality of life and pulmonary function in patients with COPD and inhaler device preferences
por: Ohno, Takeshi, et al.
Publicado: (2014)

Characterization of the bronchodilatory dose response to indacaterol in patients with chronic obstructive pulmonary disease using model-based approaches
por: Renard, Didier, et al.
Publicado: (2011)

Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease
por: Burgel, Pierre-Régis, et al.
Publicado: (2017)

Clinical benefit of fixed-dose dual bronchodilation with glycopyrronium and indacaterol once daily in patients with chronic obstructive pulmonary disease: a systematic review
por: Ulrik, Charlotte Suppli
Publicado: (2014)

Effects of indacaterol versus tiotropium on respiratory mechanics assessed by the forced oscillation technique in patients with chronic obstructive pulmonary disease
por: Inui, Naoki, et al.
Publicado: (2015)

Once-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterol
por: Roskell, Neil S, et al.
Publicado: (2014)

Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide
por: Ridolo, Erminia, et al.
Publicado: (2019)

Effect of Indacaterol on Cough and Phlegm in Chronic Obstructive Pulmonary Disease Patients: A Meta-Analysis of Five Randomized Controlled Trials
por: Park, Jinkyeong, et al.
Publicado: (2015)

Long-acting β-adrenoceptor agonists in the management of COPD: focus on indacaterol
por: Beier, Jutta, et al.
Publicado: (2011)

Indacaterol on dyspnea in chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized placebo-controlled trials
por: Han, Jiangna, et al.
Publicado: (2013)

Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease - a randomized, multicenter, double-blind, placebo-controlled study
por: Watz, Henrik, et al.
Publicado: (2014)

Indacaterol therapy in moderate-to-severe chronic obstructive pulmonary disease: findings from a single-center primary care cohort
por: Singh, Mukesh P
Publicado: (2013)

Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England
por: Requena, Gema, et al.
Publicado: (2023)

Indacaterol: a comprehensive review
por: Rossi, Andrea, et al.
Publicado: (2013)

Real-world Safety and Efficacy of Indacaterol/Glycopyrronium in Japanese Patients with Chronic Obstructive Pulmonary Disease: A 52-week Post-marketing Surveillance
por: Kato, Chihiro, et al.
Publicado: (2021)

Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial
por: Kalberg, Chris, et al.
Publicado: (2016)

Real-world Safety and Efficacy of Indacaterol Maleate in Patients with Chronic Obstructive Pulmonary Disease: Evidence from the Long-term Post-marketing Surveillance in Japan
por: Taniguchi, Tomoko, et al.
Publicado: (2021)

Evaluation of Quality of Life with the Chronic Obstructive Pulmonary Disease Assessment Test in Chronic Obstructive Pulmonary Disease and the Effect of Dyspnea on Disease-Specific Quality of Life in These Patients
por: Okutan, Oguzhan, et al.
Publicado: (2013)

Clinical role of dual bronchodilation with an indacaterol–glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality of life
por: Rossi, Andrea, et al.
Publicado: (2015)

Sleep quality predicts quality of life in chronic obstructive pulmonary disease
por: Scharf, Steven M, et al.
Publicado: (2011)

Safety of indacaterol in the treatment of patients with COPD
por: Donohue, James F, et al.
Publicado: (2011)

Health-related quality of life in chronic obstructive pulmonary disease
por: Rai, Deependra Kumar
Publicado: (2021)

Correlation of health-related quality of life with other disease severity indices in Indian chronic obstructive pulmonary disease patients
por: Shavro, Seema Aziyakath, et al.
Publicado: (2012)

Indacaterol and glycopyrronium versus indacaterol on body plethysmography measurements in COPD—a randomised controlled study
por: Salomon, Joerg, et al.
Publicado: (2017)

Management of chronic obstructive pulmonary disease: A review focusing on exacerbations
por: Bollmeier, Suzanne G, et al.
Publicado: (2020)

Comparative efficacy of indacaterol 150 μg and 300 μg versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease – a network meta-analysis
por: Cope, Shannon, et al.
Publicado: (2011)

Health-related quality of life in chronic obstructive pulmonary disease patients in Korea
por: Kim, Seon-Ha, et al.
Publicado: (2014)

Quality of life of patients with schizophrenia and chronic obstructive pulmonary disease: An observational study
por: Ramadas, Smitha, et al.
Publicado: (2017)

Nonadherence to treatment and quality of life among patients with chronic obstructive pulmonary disease
por: Mohsen, Shorouk, et al.
Publicado: (2019)

Analysis of two questionnaires on quality of life of Chronic Obstructive Pulmonary Disease patients
por: Ayora, Ana Folch, et al.
Publicado: (2019)

Is Inhaler Technique Associated with Quality of Life in Patients with Chronic Obstructive Pulmonary Disease?
por: Amini, Shahideh, et al.
Publicado: (2020)

Technological advances and digital solutions to improve quality of life in older adults with chronic obstructive pulmonary disease: a systematic review
por: Lippi, Lorenzo, et al.
Publicado: (2023)

Artificial Intelligence and Machine Learning in Chronic Airway Diseases: Focus on Asthma and Chronic Obstructive Pulmonary Disease
por: Feng, Yinhe, et al.
Publicado: (2021)

Early life influences on the development of chronic obstructive pulmonary disease
por: Stocks, Janet, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1t65jfcnh049sb934cdragp2uc